| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1047227671 |
| P356 | DOI | 10.1038/300611A0 |
| P932 | PMC publication ID | 4881848 |
| P698 | PubMed publication ID | 6958982 |
| P2093 | author name string | M G Rosenfeld | |
| R M Evans | |||
| R E Hammer | |||
| R D Palmiter | |||
| R L Brinster | |||
| M E Trumbauer | |||
| N C Birnberg | |||
| P2860 | cites work | Transcriptional regulation of the mouse metallothionein-I gene by heavy metals | Q70797480 |
| The mouse metallothionein-I gene is transcriptionally regulated by cadmium following transfection into human or mouse cells | Q72045401 | ||
| Recovery of DNA segments from agarose gels | Q72846172 | ||
| Synthesis and release of human growth hormone from lung carcinoma in cell culture | Q93716312 | ||
| Genetic transformation of mouse embryos by microinjection of purified DNA | Q24608157 | ||
| Direct expression in Escherichia coli of a DNA sequence coding for human growth hormone | Q28305861 | ||
| Stimulation of growth in the little mouse | Q28513361 | ||
| Integration and Stable Germ Line Transmission of Genes Injected into Mouse Pronuclei | Q34252877 | ||
| Somatic expression of herpes thymidine kinase in mice following injection of a fusion gene into eggs | Q34253051 | ||
| Introduction of a rabbit beta-globin gene into the mouse germ line | Q34273747 | ||
| Effect of Exogenous Growth Hormone on Lactational Performance in High Yielding Dairy Cows | Q34283511 | ||
| Primary structure and evolution of rat growth hormone gene | Q35458269 | ||
| The human beta-globin gene and a functional viral thymidine kinase gene in developing mice. | Q35463665 | ||
| Transformation of frog embryos with a rabbit beta-globin gene | Q35464659 | ||
| Introduction of rat growth hormone gene into mouse fibroblasts via a retroviral DNA vector: expression and regulation | Q36289669 | ||
| Microinjection of a rabbit beta-globin gene into zygotes and its subsequent expression in adult mice and their offspring | Q36375465 | ||
| Thyrotropin-releasing hormone exerts rapid nuclear effects to increase production of the primary prolactin mRNA transcript | Q36377131 | ||
| Expression of two human growth hormone genes in monkey cells infected by simian virus 40 recombinants | Q36382125 | ||
| Growth hormone and the regulation of somatic growth | Q37367776 | ||
| Brain peptides (first of two parts). | Q40083919 | ||
| The regulation of growth by endocrines | Q40682318 | ||
| Structure of mouse metallothionein-I gene and its mRNA. | Q42268759 | ||
| Growth hormone and the adipose conversion of 3T3 cells | Q42825109 | ||
| Regulation of metallothionein–thymidine kinase fusion plasmids injected into mouse eggs | Q48405546 | ||
| Microinjection of cloned retroviral genomes into mouse zygotes: integration and expression in the animal. | Q53569555 | ||
| Solubilization and purification of a prolactin receptor from the rabbit mammary gland. | Q54647924 | ||
| Regulated expression of human growth hormone genes in mouse cells | Q62059799 | ||
| Pituitary adenomas in childhood and adolescence | Q67356469 | ||
| Ectopic growth-hormone production and osteoarthropathy in carcinoma of the bronchus | Q70083464 | ||
| Differential regulation of metallothionein-thymidine kinase fusion genes in transgenic mice and their offspring | Q70448542 | ||
| P433 | issue | 5893 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 611-615 | |
| P577 | publication date | 1982-12-01 | |
| P1433 | published in | Nature | Q180445 |
| P1476 | title | Dramatic growth of mice that develop from eggs microinjected with metallothionein-growth hormone fusion genes | |
| P478 | volume | 300 |
| Q73311056 | 'Molecular farming' of antibodies in plants |
| Q41703005 | A consideration of some notable aging theories |
| Q48247606 | A dietary supplement abolishes age-related cognitive decline in transgenic mice expressing elevated free radical processes |
| Q35550198 | A future for transgenic livestock. |
| Q35290041 | A molecular biological approach to reducing dietary amino acid needs |
| Q48723423 | A multi-ingredient dietary supplement abolishes large-scale brain cell loss, improves sensory function, and prevents neuronal atrophy in aging mice |
| Q37366031 | A non-surgical approach for male germ cell mediated gene transmission through transgenesis |
| Q34381923 | A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice |
| Q31423344 | A transgenic mouse expressing human CYP1A2 in the pancreas |
| Q37359089 | Accelerated growth and visceral lesions in transgenic mice expressing foreign genes of the growth hormone family: an overview |
| Q37375570 | Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice. |
| Q37125980 | Age-related changes in body composition of bovine growth hormone transgenic mice |
| Q28593220 | Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis |
| Q37352313 | Altering nutrient utilization in animals through transgenesis |
| Q39816011 | An appraisal of the application of recombinant DNA techniques to chromosome defects |
| Q36887080 | Analysis of a transgenic mouse containing simian virus 40 and v-myc sequences |
| Q35817599 | Animal models of human disease. Pathology and molecular biology of spontaneous neoplasms occurring in transgenic mice carrying and expressing activated cellular oncogenes |
| Q36631641 | Animal models of skin disease for drug discovery. |
| Q34608788 | Animal transgenesis: state of the art and applications |
| Q44850419 | Antisense Inhibition of β-Glucuronidase Expression in Preimplantation Mouse Embryos: A Comparison of Transgenes and Oligodeoxynucleotides |
| Q36587260 | Application of recombinant DNA technologies to studies on chicken growth hormone |
| Q37508177 | Assessment of fecundity and germ line transmission in two transgenic pig lines produced by sleeping beauty transposition |
| Q50790654 | Association of (3H) DNA with fowl spermatozoa and their in vitro fertilisation of hamster ova |
| Q49588153 | Avian Biotechnology |
| Q35186506 | Behavioural and physiological characterization of inbred mouse strains: prospects for elucidating the molecular mechanisms of mammalian learning and memory |
| Q39737833 | Beta cell expression of IGF-I leads to recovery from type 1 diabetes. |
| Q33930330 | Biogerontological research in Canada |
| Q39691811 | Biotechnology and production-related hormones |
| Q37036325 | Body-enlarging effect of royal jelly in a non-holometabolous insect species, Gryllus bimaculatus. |
| Q35588234 | Brains, genes, and primates |
| Q35655803 | Breeding and transgenesis as means of decreasing adiposity in farm animal species: practice and promise |
| Q37259329 | Breeding for disease resistance--the prospective role of genetic manipulation |
| Q42471375 | CD14 transgenic mice expressing membrane and soluble forms: comparisons of levels of cytokines and lethalities in response to lipopolysaccharide between transgenic and non-transgenic mice |
| Q35209756 | CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis |
| Q34386193 | Cancer immunotherapy: insights from transgenic animal models |
| Q35762709 | Capricious Cre: the devil is in the details |
| Q48894839 | Caprine blastocyst development after in vitro fertilization with spermatozoa frozen in different extenders |
| Q33191658 | Cell-specific expression of a Clara cell secretory protein-human growth hormone gene in the bronchiolar epithelium of transgenic mice |
| Q28585768 | Characterization and localization of mouse hypothalamic growth hormone-releasing factor and effect of gold thioglucose-induced hypothalamic lesions |
| Q40914931 | Chemical regulation of transgene expression in plants |
| Q70671273 | Chromosomal transplantation. The nuclear transplantation of colchicine-treated cells |
| Q27931785 | Cloning and expression of a yeast copper metallothionein gene |
| Q35630884 | Conditional Cripto overexpression in satellite cells promotes myogenic commitment and enhances early regeneration |
| Q74603817 | Consequences of overexpression of growth hormone in transgenic mice on liver cytochrome P450 enzymes |
| Q38980833 | Construction of a recombinant human insulin expression vector for mammary gland-specific expression in buffalo (Bubalus bubalis) mammary epithelial cell line |
| Q34334407 | Consuming transgenic goats' milk containing the antimicrobial protein lysozyme helps resolve diarrhea in young pigs |
| Q36268666 | Copper metallothionein of yeast, structure of the gene, and regulation of expression |
| Q59053963 | Correcting an immune-response deficiency by creating Eα gene transgenic mice |
| Q37403955 | Crosstalk between growth hormone and insulin signaling |
| Q34659803 | Cruciform-extruding regulatory element controls cell-specific activity of the tyrosine hydroxylase gene promoter |
| Q33743426 | Culture time of vitrified/warmed zygotes before microinjection affects the production efficiency of CRISPR-Cas9-mediated knock-in mice. |
| Q41566520 | DNA binding properties of glucocorticosteroid receptors bound to the steroid antagonist RU-486 |
| Q36573408 | Decompartmentalizing target validation-thinking outside the pipeline boxes |
| Q47432294 | Decreased frequency of the rat growth hormone transgene in mouse populations with or without selection for increased adult body weight |
| Q36753290 | Derepression of human embryonic zeta-globin promoter by a locus-control region sequence |
| Q33873910 | Developing efficient strategies for the generation of transgenic cattle which produce biopharmaceuticals in milk |
| Q53802217 | Development of a positive method for male stem cell-mediated gene transfer in mouse and pig. |
| Q41714073 | Development of expression vectors for transgenic fish |
| Q70972856 | Development of obesity following inactivation of a growth hormone transgene in mice |
| Q51842182 | Development of transgenic fish for ornamental and bioreactor by strong expression of fluorescent proteins in the skeletal muscle. |
| Q52457371 | Developmental control of transduced dopa decarboxylase genes in D. melanogaster. |
| Q70409679 | Developmental fate of a human insulin gene in a transgenic mouse |
| Q36903431 | Developmental regulation of alpha-fetoprotein genes in transgenic mice |
| Q40517143 | Differential expression of jun and fos genes during differentiation of mouse P19 embryonal carcinoma cells |
| Q74474271 | Differential in vivo activities of bovine growth hormone analogues |
| Q30449971 | Differentiation, not determination, regulates muscle gene activation: transfection of troponin I genes into multipotential and muscle lineages of 10T1/2 cells |
| Q70313579 | Direct alteration of a gene in the human genome |
| Q34631775 | Direct gene transfer into human cultured cells facilitated by laser micropuncture of the cell membrane |
| Q35882691 | Direct sequencing of PCR-amplified junction fragments from tandemly repeated transgenes |
| Q37579154 | Direct transfection of viral and plasmid DNA into the liver or spleen of mice |
| Q37117583 | Domestication and growth hormone transgenesis cause similar changes in gene expression in coho salmon (Oncorhynchus kisutch). |
| Q35904811 | Dominant dwarfism in transgenic rats by targeting human growth hormone (GH) expression to hypothalamic GH-releasing factor neurons |
| Q40053591 | Drug discovery paradigms: past, present, future - a centennial symposium of the American Society for Pharmacology and Experimental Therapeutics |
| Q50612461 | Effect of crotamine, a cell-penetrating peptide, on blastocyst production and gene expression of in vitro fertilized bovine embryos. |
| Q44870357 | Effect of genetic background on growth of mice hemizygous for wild-type or dwarf mutated bovine growth hormone transgenes |
| Q46973436 | Effects of an S84E mutation of bovine growth hormone in transgenic mice |
| Q34258343 | Effects of chronic growth hormone hypersecretion on intrinsic contractility, energetics, isomyosin pattern, and myosin adenosine triphosphatase activity of rat left ventricle |
| Q73055528 | Effects of chronically elevated growth hormone levels on polyamine metabolism in elderly transgenic mice |
| Q34231665 | Effects of growth hormone and its secretagogues on bone. |
| Q50482608 | Effects of long-term in vitro culturing of transgenic bovine donor fibroblasts on cell viability and in vitro developmental potential after nuclear transfer. |
| Q70460523 | Effects of the expression of bovine growth hormone on the testes and male accessory reproductive glands in transgenic mice |
| Q35821035 | Efficient CRISPR/Cas9-Mediated Genome Editing in Mice by Zygote Electroporation of Nuclease |
| Q54959432 | Efficient Generation of Transgenic Buffalos (Bubalus bubalis) by Nuclear Transfer of Fetal Fibroblasts Expressing Enhanced Green Fluorescent Protein. |
| Q39874162 | Efficient mouse transgenesis using Gateway-compatible ROSA26 locus targeting vectors and F1 hybrid ES cells |
| Q35590811 | Elevated GH/IGF-I, due to somatotrope-specific loss of both IGF-I and insulin receptors, alters glucose homeostasis and insulin sensitivity in a diet-dependent manner |
| Q33892161 | Embryonic and genetic manipulation in fish. |
| Q41946940 | Embryonic stem cell differentiation models: cardiogenesis, myogenesis, neurogenesis, epithelial and vascular smooth muscle cell differentiation in vitro. |
| Q40771048 | Endocrine regulation of longitudinal bone growth. |
| Q34381917 | Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). |
| Q37619960 | European community and US-FDA approval of recombinant human antithrombin produced in genetically altered goats |
| Q37619460 | Evaluation of growth hormone (GH) action in mice: discovery of GH receptor antagonists and clinical indications |
| Q47732033 | Evaluation of the safety of daily administration of capromorelin in cats |
| Q33792575 | Ex vivo magnetofection: a novel strategy for the study of gene function in mouse organogenesis |
| Q42532915 | Expression of Growth Hormone Genes in Transgenic Mice |
| Q41880877 | Expression of a microinjected immunoglobulin gene in the spleen of transgenic mice |
| Q77704854 | Expression of a novel piscine growth hormone gene results in growth enhancement in transgenic tilapia (Oreochromis niloticus) |
| Q33932178 | Expression of foreign genes from retroviral vectors in mouse teratocarcinoma chimaeras. |
| Q67529784 | Expression of human alpha 1 antitrypsin in transgenic sheep |
| Q48488820 | Expression of human growth hormone-releasing factor in transgenic mice results in increased somatic growth. |
| Q40768879 | Expression of insulin-like growth factor-I in transgenic mice |
| Q70163257 | Expression of the chicken transferrin gene in transgenic mice |
| Q33665584 | Expression of the human growth hormone variant gene in cultured fibroblasts and transgenic mice |
| Q68928702 | Expression of the pancreatic elastase I gene in transgenic mice |
| Q79141724 | Expression vehicles used in recombinant DNA technology |
| Q59059825 | Extraordinary salmon growth |
| Q37545665 | Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs |
| Q40632699 | Five decades of progress in management of the infertile couple. |
| Q32036518 | Foreign DNA introduced into the vas deferens is gained by mammalian spermatozoa |
| Q34267275 | Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines |
| Q48469839 | Frequency dependency of NMDA receptor-dependent synaptic plasticity in the hippocampal CA1 region of freely behaving mice |
| Q26781859 | From Gene Targeting to Genome Editing: Transgenic animals applications and beyond |
| Q58161857 | From mapping to manipulating the vertebrate genome |
| Q73676243 | From mighty mice to mighty cows |
| Q38146639 | Frontiers in mammalian cell culture |
| Q34462487 | Full-speed mammalian genetics: in vivo target validation in the drug discovery process |
| Q36945352 | Functional genomics of the chicken--a model organism. |
| Q39287747 | GH and ageing: Pitfalls and new insights |
| Q38495952 | Gastrocnemius transcriptome analysis reveals domestication induced gene expression changes between wild and domestic chickens |
| Q64448553 | Gene Transfer into Sheep |
| Q37710895 | Gene delivery to Nile tilapia cells for transgenesis and the role of PI3K-c2α in angiogenesis |
| Q34114590 | Gene targeting in livestock: a preview |
| Q38174163 | Gene targeting technologies in rats: zinc finger nucleases, transcription activator-like effector nucleases, and clustered regularly interspaced short palindromic repeats |
| Q70935363 | Gene therapy |
| Q36386450 | Gene therapy for pituitary tumors. |
| Q35647626 | Gene transfer and genome-wide insertional mutagenesis by retroviral transduction in fish stem cells |
| Q58281279 | Gene transfer in fish: Potential and practice |
| Q34804785 | Gene transfer in higher animals: theoretical considerations and key concepts |
| Q39692912 | Gene transfer into mice |
| Q46855972 | Gene transfer, expression and inheritance of pRSV-rainbow trout-GH cDNA in the common carp, Cyprinus carpio (Linnaeus). |
| Q61800727 | Generating mouse models for biomedical research: technological advances |
| Q88016594 | Generation of genetically modified mice using CRISPR/Cas9 and haploid embryonic stem cell systems |
| Q70150161 | Generation of transgenic mice producing a human transthyretin variant: a possible mouse model for familial amyloidotic polyneuropathy |
| Q33669930 | Generation of transgenic mice with elevated blood pressure by introduction of the rat renin and angiotensinogen genes |
| Q40075612 | Genetic control theory of developmental events |
| Q37555007 | Genetic dissection of neural circuits and behavior in Mus musculus. |
| Q28743531 | Genetic engineering of a mouse: Dr. Frank Ruddle and somatic cell genetics |
| Q86824722 | Genetic manipulation in plant breeding: somatic versus generative |
| Q34151342 | Genetic manipulation of sex differentiation and phenotype in domestic animals |
| Q69752307 | Genetic transformation of chickens using irradiated male gametes |
| Q38714831 | Genetically engineered livestock for agriculture: a generation after the first transgenic animal research conference |
| Q36818129 | Genetically manipulated mice: a powerful tool with unsuspected caveats |
| Q39757195 | Germ-line transformation of mice |
| Q41278601 | Germline transmission of exogenous genes in chickens using helper-free ecotropic avian leukosis virus-based vectors |
| Q77630788 | Green fluorescent protein (GFP) transgenic fish and their applications |
| Q43770642 | Growth and endocrine effect of growth hormone transgene dosage in diploid and triploid coho salmon |
| Q45020496 | Growth hormone and epidermal growth factor in salivary glands of giant and dwarf transgenic mice |
| Q39469085 | Growth hormone and its modulation. |
| Q36015309 | Handmade cloned transgenic piglets expressing the nematode fat-1 gene |
| Q33194830 | Haploinsufficiency of Anx7 tumor suppressor gene and consequent genomic instability promotes tumorigenesis in the Anx7(+/-) mouse |
| Q90259593 | Harnessing genomic information for livestock improvement |
| Q74582676 | Hepatocellular kinetics and the expression of growth hormone (GH) in the livers and liver tumours of GH-transgenic mice |
| Q43470250 | Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes |
| Q67528049 | High level expression of active human alpha-1-antitrypsin in the milk of transgenic sheep |
| Q37592004 | High-frequency germ-line transmission of plasmid DNA sequences injected into fertilized zebrafish eggs |
| Q33672151 | High-level expression of biologically active human alpha 1-antitrypsin in the milk of transgenic mice |
| Q47960621 | High-level expression of recombinant human fibrinogen in the milk of transgenic mice |
| Q35599123 | Human growth hormone (hGH) secretion in milk of goats after direct transfer of the hGH gene into the mammary gland by using replication-defective retrovirus vectors |
| Q67954220 | Identification of a variant growth hormone haplotype in mice selected for high body weight |
| Q34479096 | Identified and unidentified challenges for reproductive biotechnologies regarding infectious diseases in animal and public health |
| Q81739215 | Igf-I and postnatal growth of weaver mutant mice |
| Q50246481 | In vivo gene transfer in mouse preimplantation embryos after intraoviductal injection of plasmid DNA and subsequent in vivo electroporation |
| Q52363995 | In vivo genome editing thrives with diversified CRISPR technologies. |
| Q30486155 | Incomplete restoration of Mpl expression in the mpl-/- mouse produces partial correction of the stem cell-repopulating defect and paradoxical thrombocytosis |
| Q49407511 | Incorporation of a skeletal muscle-specific enhancer in the regulatory region of Igf1 upregulates IGF1 expression and induces skeletal muscle hypertrophy. |
| Q36949196 | Inducibility of metallothionein throughout the cell cycle |
| Q41450456 | Inducible cellular transformation by a metallothionein-ras hybrid oncogene leads to natural killer cell susceptibility |
| Q59057608 | Induction of self-tolerance in mature peripheral B lymphocytes |
| Q45085478 | Infectious and Selectable Retrovirus Containing an Inducible Rat Growth Hormone Minigene |
| Q28286762 | Insertion of DNA sequences into the human chromosomal beta-globin locus by homologous recombination |
| Q36064514 | Introduction and expression of the bacterial genes cysE and cysK in eukaryotic cells |
| Q54578577 | Introduction and expression of the bacterial glyoxylate cycle genes in transgenic mice. |
| Q40078935 | Introduction of Purified Genes Into Mammalian Cell |
| Q37577456 | Introduction of a selectable gene into different animal tissue by a retrovirus recombinant vector |
| Q36957536 | Introduction of genes into the germ line of animals |
| Q82467878 | Introduction: Strategies for Developing Genetically Modified Mice |
| Q51805244 | Isolation of yellow catfish β-actin promoter and generation of transgenic yellow catfish expressing enhanced yellow fluorescent protein. |
| Q53669003 | Jewish bioethics and medical genetics. |
| Q33777892 | Knock your SOCS off! |
| Q34424075 | Knock-in of Enhanced Green Fluorescent Protein or/and Human Fibroblast Growth Factor 2 Gene into β-Casein Gene Locus in the Porcine Fibroblasts to Produce Therapeutic Protein |
| Q48118403 | Lactotroph hyperplasia in the pituitaries of female mice expressing high levels of bovine growth hormone |
| Q33636494 | Leptin receptor modulation of adiposity and fertility |
| Q52213037 | Liver, renal and subcutaneous histopathology in PEPCK-bGH transgenic pigs. |
| Q57271413 | Manipulating DNA: from Cloning to Knockouts |
| Q74587447 | Manipulation of gene expression in the mammalian nervous system: application in the study of neurite outgrowth and neuroregeneration-related proteins |
| Q54247120 | Manipulation of the repertoire of digestive enzymes secreted into the gastrointestinal tract of transgenic mice. |
| Q36787518 | Meiotic expression of human ornithine transcarbamylase in the testes of transgenic mice |
| Q47754084 | Metal ion-responsive transgenic Xenopus laevis as an environmental monitoring animal |
| Q34661387 | Metal-binding proteins as metal pollution indicators |
| Q40161822 | Metallothionein-Human GH Fusion Genes Stimulate Growth of Mice |
| Q35856545 | Mice transgenic for a vasopressin-SV40 hybrid oncogene develop tumors of the endocrine pancreas and the anterior pituitary. A possible model for human multiple endocrine neoplasia type 1. |
| Q36258260 | Microinsemination and nuclear transfer using male germ cells |
| Q51896478 | Microtubules are involved in regulating body length in hydra |
| Q72800974 | Mini-mouse: phenotypic characterization of a transgenic insertional mutant allelic to pygmy |
| Q36838387 | Mitogenic signaling pathways in the liver of growth hormone (GH)-overexpressing mice during the growth period |
| Q38541790 | Molecular Genetic Strategies in the Study of Corticohippocampal Circuits |
| Q39654136 | Molecular aspects, physiological function, and clinical significance of metallothioneins |
| Q35205259 | Molecular biology in nutrition |
| Q37782846 | Molecular biology of the insulin-like growth factors. Relevance to nervous system function |
| Q71111704 | Molecular biology. Enhancers, chromosome position effects, and transgenic mice |
| Q42491592 | Morphological changes in the kidney of dogs chronically exposed to exogenous growth hormone |
| Q37611843 | Mosaic expression of a tyrosinase fusion gene in albino mice yields a heritable striped coat color pattern in transgenic homozygotes |
| Q27490350 | Mouse models in liver cancer research: A review of current literature |
| Q47069162 | Mutants carrying two sma mutations are super small in the nematode C. elegans |
| Q34063520 | My career path for developing gene therapy for blinding diseases: the importance of mentors, collaborators, and opportunities |
| Q37236327 | Natural genotypes via genetic engineering |
| Q34134065 | Neuron addition and enlargement in juvenile and adult animals |
| Q35222165 | Neuropeptide gene expression in transgenic animals |
| Q78009654 | New life for sperm-mediated transgenesis? |
| Q39025466 | Non-conventional expression systems for the production of vaccine proteins and immunotherapeutic molecules |
| Q38115497 | Novel GM animal technologies and their governance. |
| Q48453883 | Novel developmental specificity in the nervous system of transgenic animals expressing growth hormone fusion genes |
| Q69378455 | Novel restriction fragment length polymorphism of the growth hormone gene in inbred rats |
| Q34617382 | One Hundred Years of Mouse Genetics: An Intellectual History. II. The Molecular Revolution (1981-2002) |
| Q36673385 | Optimization of The Electroporation Conditions for Transfection of Human Factor IX into The Goat Fetal Fibroblasts |
| Q38549724 | Organ-Size Regulation in Mammals |
| Q36706772 | Osteoblast-specific expression of growth hormone stimulates bone growth in transgenic mice |
| Q67660860 | Overexpression of TGFα in transgenic mice: Induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast |
| Q37146368 | Overexpression of Xenopus laevis growth hormone stimulates growth of tadpoles and frogs |
| Q34175241 | Overexpression of low density lipoprotein (LDL) receptor eliminates LDL from plasma in transgenic mice |
| Q86630619 | Oxidative stress in hypopituitary dwarf mice and in transgenic mice overexpressing human and bovine GH |
| Q35599755 | Pancreatic expression of human insulin gene in transgenic mice. |
| Q45862925 | Partial correction of murine hereditary growth disorder by germ-line incorporation of a new gene |
| Q43217675 | Patterning the artery wall by lateral induction of Notch signaling |
| Q67863178 | Patterns of transgene inheritance in rainbow trout (Oncorhynchus mykiss) |
| Q45737657 | Peripheral neuropathies, hepatocellular carcinomas and islet cell adenomas in transgenic mice |
| Q73820183 | Phosphorus-friendly transgenics |
| Q40769486 | Plant metallothioneins |
| Q24611750 | Precision editing of large animal genomes |
| Q33540638 | Precision genetics for complex objectives in animal agriculture |
| Q54625912 | Preventing hair loss in mice. |
| Q36766444 | Primer: molecular tools used for the understanding of endocrinology. |
| Q37596801 | Prion disease: experimental models and reality |
| Q44869823 | Production and breeding of transgenic cattle using in vitro embryo production technology |
| Q38522594 | Production of human lactoferrin and lysozyme in the milk of transgenic dairy animals: past, present, and future |
| Q36709428 | Production of transgenic mice by microinjection of DNA into vitrified pronucleate stage eggs |
| Q41616749 | Production of transgenic mice from vitrified pronuclear-stage embryos. |
| Q34193902 | Production of transgenic rabbits, sheep and pigs by microinjection |
| Q34275662 | Production of transgenic rodents by the microinjection of cloned DNA into fertilized one-cell eggs |
| Q37356657 | Progress in gene transfer by germ cells in mammals |
| Q39581991 | Prolactin and growth hormone |
| Q38224243 | Promising future for the transgenic rat in transplantation research |
| Q36922184 | Promoter and enhancer elements from the rat elastase I gene function independently of each other and of heterologous enhancers |
| Q34712084 | Promoter efficiency depends upon intragenic sequences |
| Q72399477 | Prospects for Human Gene Therapy |
| Q46962386 | Protein-tyrosine phosphatase H1 controls growth hormone receptor signaling and systemic growth |
| Q35927577 | Public health issues related with the consumption of food obtained from genetically modified organisms |
| Q33968166 | Quantitative genetics of transgenic mice: components of phenotypic variation in body weights and weight gains. |
| Q38732853 | RNAe in a transgenic growth hormone mouse model shows potential for use in gene therapy |
| Q35744332 | Rapid growth accelerates telomere attrition in a transgenic fish |
| Q44057320 | Rearrangements of microinjected recombinant DNA in the genome of transgenic mice |
| Q40892666 | Recent advances in transgenic technology |
| Q33606158 | Recombinant DNA in medicine |
| Q35062979 | Regulating the angiogenic balance in tissues |
| Q36797664 | Regulation of expression of a sheep metallothionein 1a-sheep growth hormone fusion gene in transgenic mice. |
| Q68583023 | Relative growth of the skull and postcranium in giant transgenic mice |
| Q52569977 | Reproduction in Domestic Ruminants during the Past 50 Years: Discovery to Application. |
| Q52244133 | Restriction fragment length variations and chromosome mapping of two mouse metallothionein genes, Mt-1 and Mt-2. |
| Q37914475 | Rodent laparoscopy: refinement for rodent drug studies and model development, and monitoring of neoplastic, inflammatory and metabolic diseases |
| Q33742098 | Role of growth hormone and prolactin in the control of reproduction: what are we learning from transgenic and knock-out animals? |
| Q80060734 | Role of the GH/IGF-I axis in the growth retardation of weaver mice |
| Q28508170 | SOCS2 negatively regulates growth hormone action in vitro and in vivo |
| Q34218612 | Scavenger receptor A gene regulatory elements target gene expression to macrophages and to foam cells of atherosclerotic lesions |
| Q47147062 | Scientific report on the effects of farming systems on dairy cow welfare and disease |
| Q40076283 | Scope of DNA cloning and chemical methods in development of chemotherapeutic agents |
| Q40692299 | Seiji Memorial Lecture. Transgene expression in melanocytes |
| Q47399441 | Selection for increased adult body weight in mouse lines with and without the rat growth hormone transgene |
| Q48878155 | Selection of in vitro produced, transgenic embryos by nested PCR for efficient production of transgenic goats |
| Q30631282 | Sex-specific analysis of bone mass in normal and growth hormone transgenic mice using dual energy x-ray absorptiometry (DXA) |
| Q43822327 | Sleep of transgenic mice producing excess rat growth hormone |
| Q40922217 | Somatic gene therapy. Current status and future prospects |
| Q41907365 | Somatic growth, aging, and longevity |
| Q40142821 | Some clinical implications of recombinant DNA technology with emphasis on prenatal diagnosis of hemoglobinopathies |
| Q47548145 | Streamlined ex vivo and in vivo genome editing in mouse embryos using recombinant adeno-associated viruses. |
| Q33880195 | Studies on the expression of an H-2K/human growth hormone fusion gene in giant transgenic mice |
| Q44392444 | Studies on the thyroid in transgenic mice expressing the genes for human and bovine growth hormone |
| Q57197999 | Systemic overexpression of growth hormone (GH) in transgenic FVB/N inbred mice: an optimized model for holistic studies of molecular mechanisms underlying GH-induced kidney pathology |
| Q35074875 | Tailoring the genome: the power of genetic approaches |
| Q33853035 | Targeted deletion of somatotroph insulin-like growth factor-I signaling in a cell-specific knockout mouse model |
| Q37372495 | Targeted overexpression of IGF-I evokes distinct patterns of organ remodeling in smooth muscle cell tissue beds of transgenic mice |
| Q24631266 | Targeted transgenesis |
| Q37631906 | Technical advances in rhinologic basic science research. |
| Q34990916 | Technical approaches for mouse models of human disease |
| Q35744479 | Technologies for the control of fat and lean deposition in livestock |
| Q36559706 | Testis-specific expression of a metallothionein I-driven transgene correlates with undermethylation of the locus in testicular DNA. |
| Q35644970 | The Effect of Cage Space on Behavior and Reproduction in Crl:CD1(Icr) and C57BL/6NCrl Laboratory Mice |
| Q33817029 | The GH/IGF-1 axis in ageing and longevity |
| Q82345634 | The GH/IGF-1 axis in growth and development: new insights derived from animal models |
| Q37044921 | The Gfi-1 protooncoprotein represses Bax expression and inhibits T-cell death |
| Q48684446 | The IGF-I receptor in cell growth, transformation and apoptosis |
| Q28776550 | The analysis of ontogenetic trajectories: when a change in size or shape is not heterochrony |
| Q52517175 | The cloned dopa decarboxylase gene is developmentally regulated when reintegrated into the drosophila genome |
| Q40942515 | The commercial and agricultural applications of animal transgenesis |
| Q28244375 | The construction of transgenic and gene knockout/knockin mouse models of human disease |
| Q33228041 | The effect of DNA repair defects on reproductive performance in nucleotide excision repair (NER) mouse models: an epidemiological approach |
| Q41656283 | The effect of apo E secretion on lipoprotein uptake in transfected cells |
| Q71918825 | The effect of insulin-like growth factor-1 on adult rat cardiac contractility |
| Q30053464 | The genetic engineering of production traits in domestic animals |
| Q48072556 | The growth hormone-encoding gene isolated and characterized from Labeo rohita Hamilton is expressed in CHO cells under the control of constitutive promoters in 'autotransgene' constructs |
| Q36934464 | The growth hormone-insulin-like growth factor-I axis in chronic kidney disease |
| Q38162743 | The integrated development and application of controlled reproduction techniques in Pacific salmonid aquaculture |
| Q33902482 | The mammary gland as a bioreactor: expression, processing, and production of recombinant proteins |
| Q41175237 | The mechanisms by which growth hormone brings about growth. The relative contributions of growth hormone and insulin-like growth factors |
| Q44079492 | The methods to generate transgenic animals and to control transgene expression |
| Q34258836 | The molecular genetics of human hemoglobin |
| Q38339614 | The new genetics: molecular technology and reproductive biology. |
| Q47774301 | The proximal 350 bp of 5'-flanking sequence of the human α-subunit glycoprotein hormone gene functions in the pituitary gland, but not the placenta, in transgenic mice |
| Q70463013 | The role of growth hormone in lines of mice divergently selected on body weight |
| Q37608512 | The role of insulin-like growth factor during a postischemic period - new insights into pathophysiologic pathways in cardiac tissue |
| Q35577270 | The transgenic rabbit as model for human diseases and as a source of biologically active recombinant proteins. |
| Q41074292 | The use of null mutant mice to study complex learning and memory processes |
| Q36844564 | The use of transgenic animals to study the role of growth factors in endocrinology |
| Q33850269 | Thymidine kinase obliteration: creation of transgenic mice with controlled immune deficiency |
| Q44716680 | Tissue- and developmental stage-specific expression of the rat ornithine carbamoyltransferase gene in transgenic mice |
| Q33740724 | Tissue-specific expression and methylation of a thyroglobulin-chloramphenicol acetyltransferase fusion gene in transgenic mice |
| Q39753875 | Tissue-specific expression of pancreatic genes in transgenic mice |
| Q45173092 | Tissue-specific expression of rat myosin light-chain 2 gene in transgenic mice |
| Q36962527 | Tissue-specific, developmental, hormonal, and dietary regulation of rat phosphoenolpyruvate carboxykinase-human growth hormone fusion genes in transgenic mice |
| Q72727133 | Tools of Genetic Manipulation |
| Q35200219 | Transfer of human and murine globin-gene sequences into transgenic mice |
| Q68029247 | Transformation as a method of increasing gene copy number and gene expression in the basidiomycete fungus Coprinus cinereus |
| Q82467912 | Transgene Design |
| Q48182866 | Transgene and host growth hormone gene expression in pituitary and nonpituitary tissues of normal and growth hormone transgenic salmon |
| Q33256297 | Transgene constructs in coho salmon (Oncorhynchus kisutch) are repeated in a head-to-tail fashion and can be integrated adjacent to horizontally-transmitted parasite DNA. |
| Q34114603 | Transgenic animal bioreactors |
| Q77798567 | Transgenic animal bioreactors in biotechnology and production of blood proteins |
| Q35956746 | Transgenic animal bioreactors: a new line of defense against chemical weapons? |
| Q69352129 | Transgenic animals |
| Q35946322 | Transgenic animals and nutrition research. |
| Q35354344 | Transgenic animals as bioproducers of therapeutic proteins |
| Q35595363 | Transgenic animals in biomedicine and agriculture: outlook for the future. |
| Q40845596 | Transgenic animals in endocrinological investigation |
| Q41004106 | Transgenic animals: how they are made and their role in animal production and research |
| Q35228808 | Transgenic approaches to modifying cell and tissue function |
| Q77798570 | Transgenic bioreactors |
| Q34447763 | Transgenic fish systems and their application in ecotoxicology |
| Q41230625 | Transgenic fish: present status and future directions |
| Q38675318 | Transgenic mice as future tools in risk assessment |
| Q72599106 | Transgenic mice containing growth hormone fusion genes |
| Q40878293 | Transgenic models of pituitary diseases |
| Q34533219 | Transgenic mouse model: a new approach for the investigation of endocrine pancreatic B-cell growth |
| Q33893351 | Transgenic mouse technology: principles and methods |
| Q24798608 | Transgenic nonhuman primates for neurodegenerative diseases |
| Q57174289 | Transgenic offspring by transcaryotic implantation of transgenic ovaries into normal mice |
| Q37373784 | Transgenic regulation in laboratory animals |
| Q40668836 | Transgenic science |
| Q35906330 | Transgenic studies with a keratin promoter-driven growth hormone transgene: prospects for gene therapy |
| Q34608704 | Transgenic systems in drug discovery: from target identification to humanized mice |
| Q58170991 | Transgenic technology in animal agriculture |
| Q40629944 | Transgenic tilapia and the tilapia genome |
| Q52500100 | Transmission distortion and mosaicism in an unusual transgenic mouse pedigree |
| Q37264246 | Trends in large-scale mouse mutagenesis: from genetics to functional genomics |
| Q59079278 | Tumour development: Oncogenes in transgenic mice |
| Q48921146 | Uncertainties about 'painless' animals |
| Q36191237 | Use of intracytoplasmic sperm injection (ICSI) to generate transgenic animals |
| Q35607382 | Use of mouse genetics for studying inner ear development |
| Q34320542 | Vasopressin RNA in the neural lobe of the pituitary: dramatic accumulation in response to salt loading |
| Q34578774 | Welfare issues of genetically modified animals |
| Q57638621 | What Can the Genetics Revolution Offer the Meat Industry? |
| Q34484392 | Wnt11 promotes cardiomyocyte development by caspase-mediated suppression of canonical Wnt signals |
| Q69851348 | [Current status of biotechnology in animal breeding] |
| Q54557943 | [Site specific mutagenesis by homologous recombination in embryonic stem cells] |
Search more.